G Louis Lange
Affiliations
- at Newamsterdam Pharma Co N.v. (NAMS), 2025-06-03
- Director at Epiphany Technology Acquisition Corp. (EPHY), 2022-10-04
- Director at Bioplus Acquisition Corp. (BIOS), 2021-12-03
- Director at Audentes Therapeutics Inc. (BOLD), 2020-01-15
- Director at Cymabay Therapeutics Inc. (CBAY), 2015-06-30
- Director at Esperion Therapeutics Inc. (ESPR), 2013-07-01
- Director at Maxygen Inc (MAXY), 2012-06-07
- Officer, Director at Cv Therapeutics Inc (CVTX), 2009-04-09
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| NAMS | $19.00 | 5,000 | $95,000.00 | 24,878 | 2024-02-13 | Filing |
| ESPR | $14.00 | 10,714 | $149,996.00 | 197,703 | 2013-07-01 | Filing |
| ESPR | $14.00 | 3,500 | $49,000.00 | 17,814 | 2013-07-01 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| BOLD | $59.60 | 1,000 | $59,596.30 | 13,678 | 2019-12-23 | Filing |
| BOLD | $59.60 | 10,000 | $595,993.00 | 265,799 | 2019-12-23 | Filing |
| BOLD | $32.18 | 1,000 | $32,182.00 | 14,678 | 2019-09-23 | Filing |
| BOLD | $32.66 | 245 | $8,002.39 | 275,799 | 2019-09-23 | Filing |
| BOLD | $32.15 | 9,755 | $313,613.50 | 276,044 | 2019-09-23 | Filing |